Generated by GPT-5-mini| nucleic acid | |
|---|---|
| Name | Nucleic acid |
| Caption | Representation of double helix |
| Discovered | 1869 |
| Discoverer | Friedrich Miescher |
| Type | Biomolecule |
nucleic acid
Nucleic acids are biopolymers essential to all known life, encoding and transmitting genetic information and directing biochemical processes within cells. They were first isolated in 1869 and later central to discoveries by figures such as James Watson, Francis Crick, Rosalind Franklin, Maurice Wilkins, and Friedrich Miescher. Research on nucleic acids intersects institutions like the Royal Society, Cold Spring Harbor Laboratory, Max Planck Society, and National Institutes of Health.
Nucleic acids comprise macromolecules classified principally into deoxyribonucleic acid and ribonucleic acid, with further variants including mitochondrial, chloroplast, viral, and synthetic analogs. Historical milestones in classification involve contributions from Oswald Avery, Alfred Hershey, Martha Chase, Erwin Chargaff, and organizations such as Howard Hughes Medical Institute and European Molecular Biology Laboratory. Taxonomic and nomenclature conventions have been shaped by committees at the International Union of Biochemistry and Molecular Biology and standards adopted in contexts like the Nobel Prize announcements.
Chemically, these polymers are composed of nucleotide monomers containing a nitrogenous base, a pentose sugar, and phosphate groups; structural models were crucial to debates between proponents represented by Linus Pauling and the team of Watson and Crick, and to techniques developed at facilities like Brookhaven National Laboratory and Los Alamos National Laboratory. Key properties—base pairing, antiparallel strands, helical conformations, backbone polarity, and hydrogen-bonding—were elucidated with spectroscopy and crystallography used at institutions such as X-ray Crystallography Laboratory and by scientists including Dorothy Hodgkin and John Kendrew. Variants such as Z-form helices, triple helices, and G-quadruplexes have been characterized in studies connected to Harvard University, Massachusetts Institute of Technology, Stanford University, and University of Cambridge.
In cells, nucleic acids store hereditary information, mediate transcription and translation, regulate gene expression, and participate in enzymatic and structural roles; foundational experiments by Meselson and Stahl and genetic frameworks advanced by Gregor Mendel-inspired genetics programs influenced research directions at Cold Spring Harbor Laboratory and Max Planck Institute for Molecular Genetics. DNA in chromosomes interacts with histones and chromatin remodelers studied by groups at Johns Hopkins University, University of California, Berkeley, and Yale University; RNA species including messenger, transfer, ribosomal, microRNA, and long noncoding RNAs were cataloged in projects like the ENCODE Project and in collaborations with institutions such as Wellcome Trust Sanger Institute and European Bioinformatics Institute.
Cellular synthesis pathways—DNA replication, RNA transcription, and nucleotide biosynthesis—are mediated by polymerases, ligases, primases, and nucleotide-metabolizing enzymes whose mechanisms were delineated by researchers at Salk Institute, Pasteur Institute, and Friedrich Miescher Institute. Metabolic pathways such as de novo purine and pyrimidine synthesis, salvage pathways, and nucleotide degradation involve enzymes characterized in studies funded by agencies including National Science Foundation and European Research Council, and have clinical relevance in contexts examined at Mayo Clinic, Cleveland Clinic, and John Radcliffe Hospital.
Detection and analysis techniques include Sanger sequencing, next-generation sequencing, quantitative PCR, northern and southern blotting, mass spectrometry, and cryo-electron microscopy; technological advances came from companies and labs like Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies, Pacific Biosciences, and academic centers including Broad Institute and European Molecular Biology Laboratory. Bioinformatics tools developed at EMBL-EBI, National Center for Biotechnology Information, and computational research at Stanford University and University of Oxford support annotation, assembly, and variant analysis used in initiatives like the Human Genome Project and the 1000 Genomes Project.
Applications span molecular diagnostics, gene therapy, synthetic biology, forensic science, agriculture, and biotechnology: CRISPR gene editing platforms advanced by teams at University of California, Berkeley, MIT, Broad Institute, and University of Vienna; mRNA vaccine technologies developed and deployed by companies and collaborations including Moderna, BioNTech, and Pfizer; recombinant DNA and cloning techniques pioneered in laboratories like Stanford University and University of California, San Francisco. Regulatory, ethical, and policy discussions involve transnational bodies such as the World Health Organization, European Medicines Agency, and national agencies like the FDA. Industrial and research infrastructures from Genentech to university spin-offs apply nucleic acid technologies in diagnostics, therapeutics, and agricultural biotechnology, with intellectual property considerations litigated in courts including United States Supreme Court decisions affecting patent law.